Search

everythinglearnresearchcommunity

for

Search:↓

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Spironolactone plus finasteride reduces hirsutism more effectively.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Some men with early hair loss may have a condition similar to PCOS in women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.